Cor

17 Jun, 2025

Cencora Inc. (COR) - Fundamental Analysis

Investing , Analysis , Fundamental Analysis , Healthcare , Distribution

🎯 Investment Thesis & Recommendation Core Thesis Cencora Inc. represents a compelling defensive growth play in pharmaceutical distribution, benefiting from GLP-1 drug surge and aging demogra

16 Jun, 2025

$COR SMA Cross Live Signal: GLP-1 Catalyst Meets Technical Breakout

Analysis , Live Signals , Technical Analysis , Fundamental Analysis , Short Form

📈 $COR SMA (8/26) cross just fired: 2.87 reward/risk ratio meets GLP-1 drug boom driving 36% YoY growth - rare combo of math edge + mega catalyst. Here's why this signal matters. 👇 ✅ Strategy P